XML 25 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (14,194,431) $ (6,699,562)
Adjustments to reconcile net loss to net cash used in operating activities:    
Non-cash interest expense 242,982 0
Share-based compensation 418,093 63,803
Depreciation 3,997 3,532
Loss on disposal of property and equipment 2,078 0
Write-off of deferred financing costs 1,901 67,995
Changes in operating assets and liabilities    
Prepaid expenses (336,834) (430,571)
Accounts payable (287,538) 140,011
Accrued expenses 68,144 (102,990)
Other noncurrent assets (13,648) 0
Net cash used in operating activities (14,095,256) (6,957,782)
Cash flows from investing activities:    
Cash acquired in Merger, net of payment in lieu of fractional shares 1,030,123 0
Purchase of property and equipment (62,842) (1,582)
Net cash provided by (used in) investing activities 967,281 (1,582)
Cash flows from financing activities:    
Proceeds from issuance of common stock 21,506,842 0
Proceeds from issuance of Series B Convertible Redeemable Preferred stock, net 0 7,994,837
Deferred financing costs (68,530) 0
Proceeds from convertible notes payable 5,500,000 0
Net cash provided by financing activities 26,938,312 7,994,837
Net increase in cash and cash equivalents 13,810,337 1,035,473
Cash and cash equivalents, beginning of the year 1,834,018 798,545
Cash and cash equivalents, end of the year 15,644,355 1,834,018
Supplemental cash flow information and non- cash financing transactions:    
Cash paid during the year for interest 0 720
Accretion of issuance costs on Series A Convertible Redeemable Preferred stock 51,943 14,841
Accretion of issuance costs on Series B Convertible Redeemable Preferred stock 127,780 27,382
Conversion of Series A Convertible Redeemable Preferred stock to common stock 4,166,164 0
Conversion of Series B Convertible Redeemable Preferred stock to common stock 8,149,999 0
Conversion of convertible notes payable and accrued interest to common stock 5,674,452 0
Issuance of common stock in Merger (Note 1) $ 6,978,916 $ 0